AstraZeneca Discontinues Brazikumab Inflammatory Bowel Disea

By Anthony O. Goriainoff


AstraZeneca said Thursday that it was discontinuing the brazikumab inflammatory bowel disease development program after reviewing its development timeline as well as... | June 1, 2023

Related Keywords

Sweden , Anthonyo Goriainoff , , Astrazeneca , Dow Jones , Astrazeneca Plc Stock Exchange , News , Information , Press Release , Y , Anthony , Goriainoff , Aid , Hursday , Hat , It , Gas , Discontinuing , The , Brazikumab , Inflammatory , Towel , Disease , Development , Program , After , Reviewing , Its , Timeline , Us , Ell Azn Gb0009895292 ,